PolyPid Introduces PD01B Candidate for Diabetic Foot Infections
PolyPid announced PD01B, a new Kynatrix-based product candidate for treating diabetic foot infections, as part of an expanded pipeline strategy.
Story updates
12:02:31 PM UTC
SquawkNews
Company to host virtual Investor Day today at 11:30 AM ET, featuring key opinion leader Warren S. Jo
12:04:29 PM UTC
SquawkNews
Company to host virtual Investor Day today at 11:30 AM ET, featuring key opinion leader Warren S. Joseph, DPM, FIDSAAll scheduled FDA interactions on track and aligned with D-PLEX₁₀₀ November 28, 2026 PDUFA goal date PolyPid introduces PD01B, a new product candidate targeting hyper-localized, contr…